Skip to search formSkip to main contentSkip to account menu

Cosentyx

National Institutes of Health

Related topics

Related topics

4 relations
1 ML secukinumab 150 MG/ML Auto-Injector [Cosentyx]1 ML secukinumab 150 MG/ML Prefilled Syringe [Cosentyx]Cosentyx Injectable Product

Broader (1)

secukinumab

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
5PSQ-027 Early real-world effectiveness and safety of secukinumab in patients with psoriasis
Background Secukinumab is a recently approved interleukin 17A inhibitor indicated for the treatment of patients with plaque… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)